MORRISVILLE, North Carolina, October 3, 2016 /PRNewswire/ --
Worldwide Clinical Trials (http://www.worldwide.com)
During his presentation, Zucker will discuss the innovative ways in which sponsors can approach feasibility, focusing on the use of Monte Carlo simulations in determining the best probability of success for trial strategies. The session will support MAGI's "Sponsor Operations: Innovative Methods for Protocol Feasibility" element of the conference, and will take place on Monday, Oct. 24 at 1:30 pm P.T.
"The use of Monte Carlo simulations provides the basis of successful data-driven trial planning," said Zucker, who has more than 20 years' experience in clinical research operations. "During my presentation at MAGI, I will explore how the use of these modeling and simulation methods can work to capture the possible risks and outcomes for any given scenario, helping sponsors and investigative sites to reduce their study costs and timelines, while optimizing the chances of study success."
MAGI's Clinical Research Conference will offer four days of sessions and workshops in six tracks: sponsor operations, site operations, contracts, budgets and billing, regulatory compliance and quality. For futher information, visit http://www.magiworld.org/.
In addition to the MAGI cconference, Zucker will join a panel session at the Global Site Solutions Summit 2016, discussing how organizations can "Stand Out in the Feasibility Process." Alongside representatives from Amgen, Bio-Optronics, Inc. and RealTime CTMS, Zucker will discuss how organizations can maximize their credibility and use metrics and materials to create the right first impression. The panel session will take place on Saturday, Oct. 15 at 2:30 pm E.T. at the Waldorf Astoria in Boca Raton, FL. For more information, visit http://sitesolutionssummit.com/.
Connect with Worldwide Clinical Trials:
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit http://www.worldwide.com.
SOURCE Worldwide Clinical Trials
Subscribe to our Free Newsletters!
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...View All